Drug · DIN 02433192
AMLODIPINE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 1, 2017.
- Drug Identification Number (DIN)
- 02433192
- Company (DIN owner)
- Actavis Pharma CompanyToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Amlodipine C08CA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMLODIPINE (AMLODIPINE BESYLATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 24, 2014: NOC 16335Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named AMLODIPINE
- DIN 02326795 · Marketed
- DIN 02326809 · Marketed
- DIN 02326817 · Marketed
- DIN 02331284 · Marketed
- DIN 02331292 · Marketed
- DIN 02385783 · Marketed
- DIN 02385791 · Marketed
- DIN 02385805 · Marketed
- DIN 02429217 · Marketed
- DIN 02429225 · Marketed
- DIN 02478587 · Marketed
- DIN 02490781 · Marketed
- DIN 02490803 · Marketed
- DIN 02490811 · Marketed
- DIN 02492199 · Marketed
- DIN 02552868 · Marketed
- DIN 02552876 · Marketed
- DIN 02552884 · Marketed
- DIN 02343193 · Cancelled Post Market
- DIN 02343207 · Cancelled Post Market